A detailed history of Core Cap Advisors, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Core Cap Advisors, LLC holds 44,787 shares of ANIX stock, worth $120,477. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44,787
Previous 46,894 4.49%
Holding current value
$120,477
Previous $103,000 36.89%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$2.21 - $3.48 $4,656 - $7,332
-2,107 Reduced 4.49%
44,787 $141,000
Q2 2024

Aug 08, 2024

BUY
$2.21 - $3.35 $103,635 - $157,094
46,894 New
46,894 $103,000
Q1 2024

Aug 08, 2024

SELL
$3.08 - $5.02 $8,008 - $13,051
-2,600 Reduced 5.54%
44,294 $138,000
Q4 2022

Feb 10, 2023

SELL
$3.78 - $5.81 $4,449 - $6,838
-1,177 Reduced 3.15%
36,209 $153,000
Q3 2022

Feb 10, 2023

BUY
$2.81 - $6.15 $702 - $1,537
250 Added 0.67%
37,386 $191,000
Q2 2022

Aug 11, 2022

SELL
$2.55 - $4.1 $1,224 - $1,967
-480 Reduced 1.28%
37,136 $114,000
Q1 2022

Apr 29, 2022

BUY
$2.5 - $3.42 $6,660 - $9,110
2,664 Added 7.62%
37,616 $103,000
Q4 2021

Feb 10, 2022

BUY
$2.88 - $5.5 $100,661 - $192,236
34,952 New
34,952 $104,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $82.5M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.